Hisada Shigeru | Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
スポンサーリンク
概要
- HISADA Shigeruの詳細を見る
- 同名の論文著者
- Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.の論文著者
関連著者
-
Hisada Shigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
Shibata Seiji
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Isobe Mitsui
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
TANIFUJI Hisato
Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
TANIFUJI Hisato
Teikoku Hormone Mfg. Co., Ltd.
-
Tanifuji Hisato
Teikoku Hormone Mfg. Co. Ltd.
-
Nagashima Masako
Teikoku Hormone Mfg. Co. Ltd.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Sigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Hisada Shigeru
Teikoku Hormone Mfg. Co. Ltd.
-
Sato Atsuko
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
NAGASAKI Syuji
Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
Usui Toshimi
Central Institute for Experimental Animals
-
Usui Toshimi
Central Institute Of Experimental Animals
-
ISOBE Mitsui
Safety Research Department, Teikoku Hormone Mfg.Co.Ltd.
-
Iizuka Kazuhiro
Teikoku Hormone Mfg. Co. Ltd.
-
IKEDA Takashi
Safety & Pharmacokinetics Research Dep., Teikoku Hormone Mfg. Co., Ltd.
-
SHIBATA Seiji
Safety & Pharmacokinetics Research Dep., Teikoku Hormone Mfg. Co., Ltd.
-
NAGASHIMA Masako
Teikoku Hormone Mfg. Co., Ltd.
-
SHIBATA Seiji
Teikoku Hormone Mfg. Co., Ltd.
-
Araki Sei-ichi
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Ootake Sachiyo
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Nagasaki Syuji
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Tanifuji Hisato
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Ikeda Takashi
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Ohno Yasuo
第一三共安全性研究所
-
Yoshida Midori
National Institute of Health Sciences
-
Ohno Yasuo
National Institute of Health Sciences
-
Yoshida Midori
Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida M
National Agricultural Research Center For Hokkaido Region
-
Yoshida Midori
Division Of Pathology National Institute Of Health Sciences
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Yoshida M
Genomic Sciences Center Riken
-
Iizuka Kazuhiro
Safety Resarch Department, Teikoku Hormone Mfg Co., Ltd.
-
Yoshida Midori
Dept.pathol. Sasaki Inst.
-
Masuda Syuji
Teikoku Hormone Mfg. Co. Ltd.
-
OHTAKE Sachiyo
Safety & Pharmacokinetics Research Dep., Teikoku Hormone Mfg. Co., Ltd.
-
Araki Sei-ichi
Safety & Pharmacokinetics Research Department, Teikoku-Hormone Mfg. Co., Ltd.
-
Ootake Sachiyo
Safety & Pharmacokinetics Research Department, Teikoku-Hormone Mfg. Co., Ltd.
-
MORIMOTO Hideki
Teikoku Hormone Mfg. Co., Ltd.
-
MASUDA Shuji
Teikoku Hormone Mfg. Co., Ltd.
-
SATO Atsuko
Teikoku Hormone Mfg. Co., Ltd.
-
ISOBE Mitsui
Teikoku Hormone Mfg. Co., Ltd.
-
Matsuda Yuzuru
President Kyowa Hakko Kogyo Co. Ltd.
-
Matsuda Yuzuru
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Yoshida M
National Food Research Institute
-
Sanbuissho Atsushi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Masuda Shuji
Teikoku Hormone Mfg. Co. Ltd.
-
Yamasaki M
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Sanbuissho Atsushi
Medicinal Safety Res. Laboratories Daiichi Sankyo Co. Ltd.
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Yoshida M
Kyowa Hakko Kogyo Co. Ltd. Tokyo Jpn
-
Morimoto Hideki
Teikoku Hormone Mfg. Co. Ltd.
-
Morimoto Hideki
Teikoku Hormone Mfg
-
Ohno Yasuo
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
IIZUKA Kazuhiro
Teikoku Hormone Mfg. Co., Ltd.
-
Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
YOSHIDA Midori
Division of Pathology, National Institute of Health Sciences
-
SANBUISSHO Atsushi
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Kumazawa Toshihiko
Safety Assessment Laboratory Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kumazawa Toshihiko
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kudo Satoshi
Research Center, Kyorin Pharmaceutical Co., Ltd.
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Komatsu Shinichi
Pre-Clinical Development Department, Development & Medical Affairs Division, GlaxoSmithKline K.K.
-
Kudo Satoshi
Research Center Kyorin Pharmaceutical Co. Ltd.
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Hisada Shigeru
Safety And Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
IWAMURA Satoshi
Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
Nishikawa Akiyoshi
Division Of Pathology Biology Safety Research Center National Institute Of Health Sciences
-
Sanbuissyo Atsushi
Medical Safety Research Laboratories, R & D Division, Daiichi-Sankyo Co., Ltd.
-
Takahashi Michihito
Pathology Peer Review Center
-
Yoshida Sinya
Safety Resarch Department Teikoku Hormone Mfg Co. Ltd.
-
Yosida Shinya
Safety Resarch Department, Teikoku Hormone Mfg Co., Ltd.
-
Horiuchi Toshi
Safety Resarch Department, Teikoku Hormone Mfg Co., Ltd.
-
Suzuki Minoru
Safety Resarch Department, Teikoku Hormone Mfg Co., Ltd.
-
Iida Noriko
Teikoku Hormone Mfg. Co. Ltd.
-
Yoshida Midori
National Agricultural Research Center For Hokkaido Region
-
Horiuchi Toshi
帝国臓器製薬
-
Horiuchi Toshi
Safety Resarch Department Teikoku Hormone Mfg Co. Ltd.
-
Komatsu Shinichi
Pre-clinical Development Department Development & Medical Affairs Division Glaxosmithkline K.k.
-
ARAKI Seiichi
Safety & Pharmacokinetics Research Dep., Teikoku Hormone Mfg. Co., Ltd.
-
Katsuta Motoko
Safety & Pharmacokinetics Research Department, Teikoku-Hormone Mfg. Co., Ltd.
-
NAGASHIMA Masako
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
MASUDA Shuji
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
MIMURA Yuuichi
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
NAKAYAMA Takaharu
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
Katsuta Motoko
Safety & Pharmacokinetics Research Department Teikoku-hormone Mfg. Co. Ltd.
-
Iwamura Satoshi
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Mimura Yuuichi
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
Nakayama Takaharu
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
Fukui Motoko
Safety Research Department, Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
Ootake Sachiyo
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Suzuki Minoru
Department Of Applied Biological Chemistry Graduate School Of Agricultural And Life Sciences The Uni
-
Suzuki Minoru
Safety Resarch Department Teikoku Hormone Mfg Co. Ltd.
-
Kumazawa T.
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltb.
-
Fukui Motoko
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Suzuki Minoru
Safety Research Department Teikoku Hormone Mfg.co.ltd.
著作論文
- Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
- Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection
- W1-2 ICH Survey on Immunotoxicity Data(WORKSHOP 1: CURRENT OF ICH GUIDANCE ON IMMUNOTOXICITY TEST)(Proceedings of the 31st Annual Meeting)
- PD1-2 Role of histopathology in immunotoxicity evaluation(PANEL DISCUSSION 1: RECENT STATUS AND FUTURE PERSPECTIVES OF IMMUNOTOXICOLOGY)(Proceedings of the 31st Annual Meeting)
- Relationship between the accumulation of p53 protein and the level of DNA damage induced by ENNG and mitomycin C in human hepatoma HepG2 cells(Mutagenicity, Carcinogenicity, Proceedings of the 32nd Annual Meeting)
- O-21 An investigation of a possible method of genotoxic screening using RT-PCR analysis of p53-regulated genes(MUTAGENICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Genotoxicity screening on an early phase of drug development using Ames miniscreen assay and in vitro micronucreus test (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Complete parallelism between enhancement of dopamine β -hydroxylase activity and increase in the rate of cell proliferation in adrenal medulla of male rats after reserpine treatment.
- Effects of in utero propylthiouracil exposure on the monoamine content of the rat fetus brain(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
- Effects of the p38 MAP kinase inhibitor SB203580 on the immune system of rats(Immune system, Allergy, Proceedings of the 32nd Annual Meeting)
- Tissue distribution of rat plasma released enzymes(Blood, Proceedings of the 32nd Annual Meeting)
- P-66 Effects of Tamoxlfen Treatment on the Uterus and Ovary In Rats.(Proceedings of the 27th Annual Meeting)
- P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
- 22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
- 21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
- Collaborative work on evaluation of ovarian toxicity : 1) Effects of 2- or 4-week repeated-dose administration and fertility studies with medroxyprogesterone acetate in female rats